about
Academic doping or Viagra for the brain? The history of recreational drug use and pharmacological enhancement can provide insight into these uses of neuropharmaceuticalsThe Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac AbnormalitiesSafety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database.Management of sexual dysfunction in Parkinson's disease.Synergetic effect of testosterone and phophodiesterase-5 inhibitors in hypogonadal men with erectile dysfunction: A systematic reviewRoflumilast: a phosphodiesterase-4 inhibitor for the treatment of respiratory disease.Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction.Management strategies in SSRI-associated sexual dysfunction in women at midlife.The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction.Avanafil - a further step to tailoring patient needs and expectations.Duration of erectile dysfunction and its relationship to treatment seeking and satisfaction with treatment using PDE5 inhibitors.Changes in the pharmacokinetic of sildenafil citrate in rats with Streptozotocin-induced diabetic nephropathy.Treatment of obstructive airway diseases with roflumilast, a novel phosphodiesterase 4 inhibitor.Testicular cancer: addressing the psychosexual issues.Urogenital dysfunction in patients with multiple sclerosis.Sildenafil-associated hepatotoxicity.Testosterone and erectile function in hypogonadal men unresponsive to tadalafil: results from an open-label uncontrolled study.Penile Erection Induced by Scoparone from Artemisia capillaris through the Nitric Oxide-Cyclic Guanosine Monophosphate Signaling Pathway.Effects of taking tadalafil 5 mg once daily on erectile function and total testosterone levels in patients with metabolic syndrome.
P2860
Q24634197-989CE5FE-5432-4739-BB02-9029F6DDBFD6Q28551385-EA0C32CD-8D37-4AE5-B0D1-A0FB99158DC0Q33606588-6543AA0F-7DF1-468A-B276-793D8C7F8417Q35588404-F6092CB9-A8EF-422B-99F0-85E68ED05565Q36207705-9F86F40B-792F-4BB6-A8F2-292406354B7CQ36568745-15EA33C4-7ACD-489A-AEAA-D020D2E68BEEQ36572591-9508D865-7817-4935-8A7C-94F32803E6E8Q38003720-BC1F1943-F7E6-4D6D-9B6F-F6808E51248DQ38692296-CF787456-BA3E-492A-B6C2-D0D53AD65879Q38846047-752B1E8F-9608-4DC1-AAF7-3619C57728A9Q40107834-2A389F16-D6B7-4A46-BDF8-173F1988D949Q41951810-E68073C3-7751-4133-B6D7-85653000EB67Q43061680-C150BC41-11D2-41DF-8226-133C878C00AFQ43228514-A3C33FBE-04E2-41CD-8B06-878E2C4AEF32Q44272495-951F4739-8854-48D9-A9B0-B10CFC9AA1DBQ46640017-0832BAE9-D79F-434C-9DC0-91D1895584DDQ46984861-B71975D3-36F0-42B3-B33E-71AEF3ECA866Q47111265-C999BE45-4C4C-4D51-8CEE-9E17A240BF12Q48682809-7A8A1EFA-470B-4B9F-9D9A-C50352F6F316
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Sildenafil in erectile dysfunction: a critical review.
@ast
Sildenafil in erectile dysfunction: a critical review.
@en
type
label
Sildenafil in erectile dysfunction: a critical review.
@ast
Sildenafil in erectile dysfunction: a critical review.
@en
prefLabel
Sildenafil in erectile dysfunction: a critical review.
@ast
Sildenafil in erectile dysfunction: a critical review.
@en
P1476
Sildenafil in erectile dysfunction: a critical review.
@en
P2093
Andrea Salonia
Patrizio Rigatti
P304
P356
10.1185/030079903125001839
P407
P577
2003-01-01T00:00:00Z